Quadrant Capital »

Corvus Pharmaceuticals shares owned by Quadrant Capital

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.9k 265 14.63

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Fundamental Us L (FNDX)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Procter & Gamble Company (PG)

View all positions for Quadrant Capital

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Vanguard Capital Management
Vivo Capital
State Street Corporation
Morgan Stanley
Deep Track Capital
Perceptive Advisors
Commodore Capital
Foresite Capital Management VI
Braidwell
Geode Capital Management
MPM Oncology Impact Management

View all funds holding Corvus Pharmaceuticals